Unity Biotechnology Statistics

Total Valuation

UBX has a market cap or net worth of $21.99 million. The enterprise value is $8.27 million.

Market Cap	21.99M
Enterprise Value	8.27M

Important Dates

The next estimated earnings date is Tuesday, August 6, 2024, after market close.

Earnings Date	Aug 6, 2024
Ex-Dividend Date	n/a

Share Statistics

UBX has 16.79 million shares outstanding. The number of shares has increased by 17.27% in one year.

Shares Outstanding	16.79M
Shares Change (YoY)	+17.27%
Shares Change (QoQ)	+6.54%
Owned by Insiders (%)	1.33%
Owned by Institutions (%)	23.97%
Float	14.62M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.92
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.98, with a Debt / Equity ratio of 0.94.

Current Ratio	4.98
Quick Ratio	n/a
Debt / Equity	0.94
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-22.99

Financial Efficiency

Return on equity (ROE) is -100.80% and return on invested capital (ROIC) is -89.30%.

Return on Equity (ROE)	-100.80%
Return on Assets (ROA)	-47.20%
Return on Capital (ROIC)	-89.30%
Revenue Per Employee	n/a
Profits Per Employee	-$1.83M
Employee Count	19
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -51.84% in the last 52 weeks. The beta is 0.91, so UBX's price volatility has been similar to the market average.

Beta (5Y)	0.91
52-Week Price Change	-51.84%
50-Day Moving Average	1.50
200-Day Moving Average	1.74
Relative Strength Index (RSI)	35.59
Average Volume (20 Days)	70,244

Short Selling Information

The latest short interest is 322,300, so 1.92% of the outstanding shares have been sold short.

Short Interest	322,300
Short Previous Month	332,426
Short % of Shares Out	1.92%
Short % of Float	2.21%
Short Ratio (days to cover)	4.19

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-41.61M
Pretax Income	-34.78M
Net Income	-34.78M
EBITDA	-32.25M
EBIT	-33.33M
Earnings Per Share (EPS)	-$2.28

Full Income Statement

Balance Sheet

The company has $36.33 million in cash and $22.61 million in debt, giving a net cash position of $13.73 million or $0.82 per share.

Cash & Cash Equivalents	36.33M
Total Debt	22.61M
Net Cash	13.73M
Net Cash Per Share	$0.82
Equity (Book Value)	23.99M
Book Value Per Share	1.43
Working Capital	30.79M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$30.96 million and capital expenditures $123,000, giving a free cash flow of -$30.83 million.

Operating Cash Flow	-30.96M
Capital Expenditures	123,000
Free Cash Flow	-30.83M
FCF Per Share	-$1.84

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

UBX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-17.27%
Shareholder Yield	-17.27%
Earnings Yield	-158.14%
FCF Yield	-140.18%

Analyst Forecast

The average price target for UBX is $9.00, which is 587.02% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$9.00
Price Target Difference	587.02%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on October 20, 2022. It was a reverse split with a ratio of 1:10.

Last Split Date	Oct 20, 2022
Split Type	Reverse
Split Ratio	1:10

Scores

Altman Z-Score	n/a
Piotroski F-Score	3